COL6A1 and neoplasm: The results indicated that COL6A1/2/3 expression had a strong positive association with stromal scores and immune scores in multiple tumor types (Fig. 3B and C), but had a negative correlation with immune scores in TGCT and THCY, indicating that elevated expression levels of three genes were correlated with lower tumor purity.